680 related articles for article (PubMed ID: 16339654)
41. Gene therapy for hemoglobinopathies: are we there yet?
Puthenveetil G; Malik P
Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560
[TBL] [Abstract][Full Text] [Related]
42. Gene therapy insertional mutagenesis insights.
Davé UP; Jenkins NA; Copeland NG
Science; 2004 Jan; 303(5656):333. PubMed ID: 14726584
[No Abstract] [Full Text] [Related]
43. Progress towards hematopoietic stem cell gene therapy.
Kurre P; Kiem HP
Curr Opin Mol Ther; 2000 Aug; 2(4):400-11. PubMed ID: 11249770
[TBL] [Abstract][Full Text] [Related]
44. [Development of gene therapy for hematopoietic stem cell using viral vectors].
Dong WJ; Zu ZX; Liu DP; Liang CC
Yi Chuan Xue Bao; 2003 Apr; 30(4):382-8. PubMed ID: 12812066
[TBL] [Abstract][Full Text] [Related]
45. [Retroviral transfer of a human beta-globin gene linked to beta locus control region hypersensitive site 2 into murine hematopoietic stem cells].
Zhai J; Liu D; Wang J
Zhonghua Yi Xue Za Zhi; 1999 Feb; 79(2):121-4. PubMed ID: 11601018
[TBL] [Abstract][Full Text] [Related]
46. A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference.
Samakoglu S; Lisowski L; Budak-Alpdogan T; Usachenko Y; Acuto S; Di Marzo R; Maggio A; Zhu P; Tisdale JF; Rivière I; Sadelain M
Nat Biotechnol; 2006 Jan; 24(1):89-94. PubMed ID: 16378095
[TBL] [Abstract][Full Text] [Related]
47. Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.
Siapati EK; Bigger BW; Miskin J; Chipchase D; Parsley KL; Mitrophanous K; Themis M; Thrasher AJ; Bonnet D
Mol Ther; 2005 Sep; 12(3):537-46. PubMed ID: 16099415
[TBL] [Abstract][Full Text] [Related]
48. Retroviral vectors for gene therapy of AIDS and cancer.
Chang LJ; He J
Curr Opin Mol Ther; 2001 Oct; 3(5):468-75. PubMed ID: 11699891
[TBL] [Abstract][Full Text] [Related]
49. Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice.
Themis M; Waddington SN; Schmidt M; von Kalle C; Wang Y; Al-Allaf F; Gregory LG; Nivsarkar M; Themis M; Holder MV; Buckley SM; Dighe N; Ruthe AT; Mistry A; Bigger B; Rahim A; Nguyen TH; Trono D; Thrasher AJ; Coutelle C
Mol Ther; 2005 Oct; 12(4):763-71. PubMed ID: 16084128
[TBL] [Abstract][Full Text] [Related]
50. eGFP reporter genes silence LCRbeta-globin transgene expression via CpG dinucleotides.
Dalle B; Rubin JE; Alkan O; Sukonnik T; Pasceri P; Yao S; Pawliuk R; Leboulch P; Ellis J
Mol Ther; 2005 Apr; 11(4):591-9. PubMed ID: 15771961
[TBL] [Abstract][Full Text] [Related]
51. Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells.
Dzierzak EA; Papayannopoulou T; Mulligan RC
Nature; 1988 Jan; 331(6151):35-41. PubMed ID: 2893284
[TBL] [Abstract][Full Text] [Related]
52. Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient.
Tubsuwan A; Abed S; Deichmann A; Kardel MD; Bartholomä C; Cheung A; Negre O; Kadri Z; Fucharoen S; von Kalle C; Payen E; Chrétien S; Schmidt M; Eaves CJ; Leboulch P; Maouche-Chrétien L
Stem Cells; 2013 Sep; 31(9):1785-94. PubMed ID: 23712774
[TBL] [Abstract][Full Text] [Related]
53. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
Sinn PL; Sauter SL; McCray PB
Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
[TBL] [Abstract][Full Text] [Related]
54. Globin lentiviral vector insertions can perturb the expression of endogenous genes in beta-thalassemic hematopoietic cells.
Hargrove PW; Kepes S; Hanawa H; Obenauer JC; Pei D; Cheng C; Gray JT; Neale G; Persons DA
Mol Ther; 2008 Mar; 16(3):525-33. PubMed ID: 18195719
[TBL] [Abstract][Full Text] [Related]
55. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
[TBL] [Abstract][Full Text] [Related]
56. Gene therapy for the hemoglobin disorders.
Persons DA; Nienhuis AW
Curr Hematol Rep; 2003 Jul; 2(4):348-55. PubMed ID: 12901333
[TBL] [Abstract][Full Text] [Related]
57. Genetic therapy for beta-thalassemia: from the bench to the bedside.
Arumugam P; Malik P
Hematology Am Soc Hematol Educ Program; 2010; 2010():445-50. PubMed ID: 21239833
[TBL] [Abstract][Full Text] [Related]
58. Lentivirus vectors in β-thalassemia.
Payen E; Colomb C; Negre O; Beuzard Y; Hehir K; Leboulch P
Methods Enzymol; 2012; 507():109-24. PubMed ID: 22365771
[TBL] [Abstract][Full Text] [Related]
59. The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number.
Persons DA; Hargrove PW; Allay ER; Hanawa H; Nienhuis AW
Blood; 2003 Mar; 101(6):2175-83. PubMed ID: 12411297
[TBL] [Abstract][Full Text] [Related]
60. Update on gene therapy for hemoglobin disorders.
Persons DA
Curr Opin Mol Ther; 2003 Oct; 5(5):508-16. PubMed ID: 14601520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
